Shenyang

CGTN: China highlights revitalizing northeast in drive for common prosperity

Retrieved on: 
Thursday, August 18, 2022

"Chinese-style modernization is modernization featuring common prosperity and happiness for all, not just a few," President Xi Jinping said in his recent inspection in northeast China's Liaoning Province.

Key Points: 
  • "Chinese-style modernization is modernization featuring common prosperity and happiness for all, not just a few," President Xi Jinping said in his recent inspection in northeast China's Liaoning Province.
  • China's northeast comprising the three provinces of Heilongjiang, Jilin and Liaoning was once a thriving powerhouse on the back of traditional industries including steel, automobile and aircraft manufacturing, shipbuilding and petroleum refining.
  • In 2003, the CPC Central Committee launched a revitalization strategy for the region and in 2016, renewed an action plan of focused supportive measures.
  • Considering China's aging population and increasing life expectancy of the elderly, aged care services should continue to expand, Xi said.

CGTN: China highlights revitalizing northeast in drive for common prosperity

Retrieved on: 
Thursday, August 18, 2022

"Chinese-style modernization is modernization featuring common prosperity and happiness for all, not just a few," President Xi Jinping said in his recent inspection in northeast China's Liaoning Province.

Key Points: 
  • "Chinese-style modernization is modernization featuring common prosperity and happiness for all, not just a few," President Xi Jinping said in his recent inspection in northeast China's Liaoning Province.
  • China's northeast comprising the three provinces of Heilongjiang, Jilin and Liaoning was once a thriving powerhouse on the back of traditional industries including steel, automobile and aircraft manufacturing, shipbuilding and petroleum refining.
  • However, afflicted by deep rooted problems including an aging population, dwindling investment and talent outflow, the region gradually showed a sharp decline in its economic performance indicators.
  • Considering China's aging population and increasing life expectancy of the elderly, aged care services should continue to expand, Xi said.

BIMI International Medical Inc. Enters Into A MOU to Acquire Chongqing Zhuoda Pharmaceutical Co, Ltd.

Retrieved on: 
Monday, August 2, 2021

NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc.(NASDAQ: BIMI) (BIMI or the Company), a leading healthcare products and services provider in China, today announced the signing of a Memorandum of Understanding (MOU) on July 30, 2021 to acquire Chongqing Zhuoda Pharmaceutical Co, Ltd.(Zhuoda).

Key Points: 
  • NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc.(NASDAQ: BIMI) (BIMI or the Company), a leading healthcare products and services provider in China, today announced the signing of a Memorandum of Understanding (MOU) on July 30, 2021 to acquire Chongqing Zhuoda Pharmaceutical Co, Ltd.(Zhuoda).
  • Pursuant to the MOU, BIMI and the owners of Zhouda have agreed to sign a stock purchase agreement (Agreement) after completing the relevant assessment and evaluation of Zhuoda.
  • It also has relationships with a number of international medical device manufactures such as GE and Philips, and large domestic medical manufacturers such as LEPU Medical and Landwind Medical.
  • About BIMI International Medical Inc.
    BIMI International Medical Inc. was founded in 2006.

China Recombinant Human Thrombopoietin (rhTPO) Market Report 2021-2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 29, 2021

The "Investigation Report on China's Recombinant Human Thrombopoietin (rhTPO) Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Investigation Report on China's Recombinant Human Thrombopoietin (rhTPO) Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • Recombinant Human Thrombopoietin (rhTPO), developed by Shenyang Sansheng Pharmaceutical Co., Ltd., was approved for marketing in China in 2005 and used to treat thrombocytopenia caused by chemotherapy.
  • According to the market research, the sales value of rhTPO in the Chinese market has increased year by year from 2016 to 2020.
  • 2 Sales of Recombinant Human Thrombopoietin in China, 2016-2020
    2.3 Sales of Recombinant Human Thrombopoietin by Dosage Form in China, 2016-2020
    3 Analysis of Major Recombinant Human Thrombopoietin Manufacturers in China, 2016-2020
    3.2 Shenyang Sansheng Pharmaceutical Co., Ltd.
    3.2.2 Sales of TPIAO (Shenyang Sansheng Pharmaceutical Co., Ltd.'s Recombinant Human Thrombopoietin) in China
    4 Prices of Recombinant Human Thrombopoietin for Different Manufacturers in China, 2020-2021
    4.1 Shenyang Sansheng Pharmaceutical Co., Ltd. (TPIAO)
    5 Prospect of Chinese Recombinant Human Thrombopoietin drug Market, 2021-2025
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210729005793/en/

BIMI International Medical Inc. Announces Appointment of New Chief Financial Officer

Retrieved on: 
Monday, July 19, 2021

NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (BIMI or the Company), a leading healthcare products and services provider in China, today announced the appointment of Amy Xue as the Companys new Chief Financial Officer, effective July 15, 2021.

Key Points: 
  • NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (BIMI or the Company), a leading healthcare products and services provider in China, today announced the appointment of Amy Xue as the Companys new Chief Financial Officer, effective July 15, 2021.
  • Prior to her appointment as BIMIs Chief Financial Officer, she served as CFO at iFresh, Inc. (NASDAQ:IFMK) between March 2020 and June 2021.
  • From July 2018 to March 2020, Xue served as CFO at XT Energy Group, Inc, in charge of XTEGs communication with SEC, investors and overseeing periodical financial reports.
  • About BIMI International Medical Inc.
    BIMI International Medical Inc. was founded in 2006.

BIMI International Medical Inc. Announces Corporate Name Change

Retrieved on: 
Monday, June 28, 2021

NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (BIMI or the Company), a leading healthcare products and services provider in China, today announcedthat on June 15, 2021, the shareholders of the Company approved an amendment to the Companys certificate of incorporation to change the Companys name from BOQI International Medical Inc. to BIMI International Medical Inc.

Key Points: 
  • NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (BIMI or the Company), a leading healthcare products and services provider in China, today announcedthat on June 15, 2021, the shareholders of the Company approved an amendment to the Companys certificate of incorporation to change the Companys name from BOQI International Medical Inc. to BIMI International Medical Inc.
  • The Companys common stock traded under the new name and the same symbol BIMI.
  • Accordingly, the Company filed a Certificate of Amendment to the Companys certificate of incorporation with the Secretary of State of the State of Delaware, which became effective on June 21, 2021.
  • About BIMI International Medical Inc.
    BIMI International Medical Inc. was founded in 2006.

BOQI International Medical Inc. Announces Results of 2021 Annual General Meeting of Stockholders

Retrieved on: 
Wednesday, June 16, 2021

NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (BIMI or the Company), a leading healthcare products and services provider in China, today announced the results of the Companys 2021 Annual General Meeting of Stockholders (the Annual Meeting) held on June 15, 2021 at 9:00 a.m. (Beijing Time), at Yuzhou Hotel, 168 Yuzhou Road, Yuzhong District, Chongqing, China.

Key Points: 
  • NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (BIMI or the Company), a leading healthcare products and services provider in China, today announced the results of the Companys 2021 Annual General Meeting of Stockholders (the Annual Meeting) held on June 15, 2021 at 9:00 a.m. (Beijing Time), at Yuzhou Hotel, 168 Yuzhou Road, Yuzhong District, Chongqing, China.
  • 1.Elected the seven nominees named in the accompanying proxy statement to serve as directors of the Company until the next annual meeting of stockholders and until their respective successors have been duly elected and qualified;
    2.
  • About BOQI International Medical Inc.
    BOQI International Medical Inc. was founded in 2006.
  • The Company is now exclusively a healthcare products and provider, offering a broad range of healthcare products and related services and operates two private hospitals in China.

The 4th Xibe Muddy Land Dragon Boat Festival in North Shenyang New District Opened Grandly

Retrieved on: 
Tuesday, June 15, 2021

SHENYANG, China, June 15, 2021 /PRNewswire/ -- "Dragon Boat in Muddy Land and Dumplings in North Shenyang New District " -- the festival with the theme of "Xibe Folk Customs and Rice Culture Coexisting" and "Crossing of Soil and Dragon Boats" was held in Shenyang on June 13th, according to the Publicity Department of North Shenyang New District.

Key Points: 
  • SHENYANG, China, June 15, 2021 /PRNewswire/ -- "Dragon Boat in Muddy Land and Dumplings in North Shenyang New District " -- the festival with the theme of "Xibe Folk Customs and Rice Culture Coexisting" and "Crossing of Soil and Dragon Boats" was held in Shenyang on June 13th, according to the Publicity Department of North Shenyang New District.
  • The Daomeng Space Spot opened a Dragon Boat Festival cultural tourism event.
  • In recent years, North Shenyang New District has successively created a number of new industrial projects featuring unique culture + resources + industries such as the Xibe Mud Festival, the Strange Slope Sophora Flower Festival, and the Ice and Snow Festival.
  • Caption: The 4th Xibe Muddy Land Dragon Boat Festival in North Shenyang New District opened grandly.

BOQI International Medical Inc. to Hold Annual Meeting of Stockholders on June 15, 2021

Retrieved on: 
Monday, June 7, 2021

NEW YORK, June 07, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (BIMI or the Company), a leading healthcare products and services provider in China, today announced that it has filed a definitive proxy statement for its 2021 annual meeting of stockholders on May 11, 2021 and expects to hold its 2021 annual meeting of stockholders on June 15, 2021 at 9:00 a.m. (Beijing Time), at the Yuzhou Hotel, 168 Yuzhou Road, Yuzhong District, Chongqing, China.

Key Points: 
  • NEW YORK, June 07, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (BIMI or the Company), a leading healthcare products and services provider in China, today announced that it has filed a definitive proxy statement for its 2021 annual meeting of stockholders on May 11, 2021 and expects to hold its 2021 annual meeting of stockholders on June 15, 2021 at 9:00 a.m. (Beijing Time), at the Yuzhou Hotel, 168 Yuzhou Road, Yuzhong District, Chongqing, China.
  • Stockholders of record at the close of business on April 30, 2021 are entitled to receive notice and vote at the annual meeting.
  • Upon email or written request to Ms. Tian Tian, Secretary, [email protected] or, BOQI International Medical Inc., Room 3601, Building A, Harbour View Place, No.
  • About BOQI International Medical Inc.
    BOQI International Medical Inc. was founded in 2006.

BOQI International Medical Inc. Announces That Its Wholesale Drug Distribution Subsidiary, Shude Pharmaceutical, Was Awarded A RMB 20 Million Contract

Retrieved on: 
Wednesday, June 2, 2021

Pursuant to the supply contract Shude Pharmaceutical will supply primarily two products, calcium carbonate and serrapeptase enteric-coated tablets to Huilian Medicine for mutual benefits with sincerity and good faith.

Key Points: 
  • Pursuant to the supply contract Shude Pharmaceutical will supply primarily two products, calcium carbonate and serrapeptase enteric-coated tablets to Huilian Medicine for mutual benefits with sincerity and good faith.
  • Under the terms of the contract, each order will, among other requirements, be subject to quality-control verification and will require payment before product delivery.
  • Mr Bangquan Tan, Sales Director at Huilian Medicine, said: We believe our cooperation with Shude Pharmaceutical, a well-regarded industry leader in wholesale drug distribution, will be very successful.
  • About BOQI International Medical Inc.
    BOQI International Medical Inc. was founded in 2006.